Samobor, Croatia
A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)
Phase
4Span
260 weeksSponsor
GlaxoSmithKlineCuiaba
Recruiting
Efficacy And Safety Of MK-6194 In Adult Participants With Systemic Lupus Erythematosus (MK-6194-006)
Phase
2Span
222 weeksSponsor
Merck Sharp & Dohme LLCCuiaba, Mato Grosso
Recruiting
1-2 of 2